Discussion
Although all patients had clinical galactorrhea, 3 were unwilling to have prolactin levels measured. Apart from hypothyroidism (6), fluoxetine, sertraline, fluvoxamine, and paroxetine therapy have been reported to cause galactorrhea (7) (8) (9) (10) . However, given that this patient's galactorrhea had a definite onset and offset with risperidone therapy, risperidone appears to be the main etiological agent for galactorrhea in this series.
There are 3 noteworthy observations in this report. First, galactorrhea can occur after many weeks of risperidone treatment (in 1 patient, it appeared during the seventh week). Second, even small dosages of risperidone (2 to 4 mg daily) can cause galactorrhea-a finding documented earlier (3)-but whether such effect is caused by potent D 2 antagonism, by drug interaction between risperidone and specific serotonin reuptake inhibitors, or by an idiosyncratic reaction needs investigation. Third, galactorrhea usually persists during risperidone treatment, and at times even after risperidone discontinuation. All these observations need further exploration.
Gamma Hydroxybutyrate Withdrawal in an Orthopedic Trauma Patient

Dear Editor
Gamma hydroxybutyrate (GHB) is a chemical initially developed in the 1960s as an anesthetic agent. It is now being investigated for use in the management of narcolepsy (1) and withdrawal from opiates (2) and alcohol (3) . Recreationally, it is used as a drug that induces euphoria (4), as a supplement for bodybuilders (5) , and as a sexual enhancer (6) . We present a case of GHB withdrawal in a 32-year-old trauma patient.
Case Report
Mr C, a 32-year-old man with a 2-year history of panic disorder, presented to the hospital following a car accident. He did not lose consciousness but suffered multiple fractures of his pelvic girdle. His vital signs were within normal limits and his CT head and toxicology screen were negative. He did not experience any panic attacks around the time of the accident or upon admission. On his second day in hospital, his heart rate rose to 110 beats per minute. He continued to remain tachycardic, and the following day, his blood pressure rose to 170/100. On his seventh day in hospital (1 day after surgery), he began to complain of confusion. Shortly thereafter, he became agitated and began having visual and auditory hallucinations. Psychiatry was consulted and he was found to be delirious according to DSM-IV criteria (7) .
Risperidone was initiated (initially 1 mg orally at night, with 0.5 mg every 2 hours as needed, then 2 mg at night the following day), with minimal effect. Collateral information suggested that chronic GHB use for anxiety (1 to 5 "capfuls" daily for 2 years) might be related to this resistance. We reviewed the literature and found that Mr C's autonomic instability and delirium were consistent with GHB withdrawal (6) . Benzodiazepines have been shown to effectively sedate patients suffering from GHB withdrawal, although the appropriate dosages remain unknown (6) . We initiated treatment with diazepam 10 mg daily on day 3 of his delirium. Twenty-four hours later, his delirium had resolved and his sleep-wake cycle returned to normal. His vital signs normalized within 3 days.
Mr C's presentation had several aspects consistent with GHB withdrawal: autonomic changes within 24 hours of discontinuing GHB use, anxiety, restlessness, confusion, delirium, visual hallucinations, and resistance to neuroleptics. However, the late onset of the delirium and the relatively quick response to diazepam are not as consistent with most reports of GHB withdrawal. Mr C's case is complicated by several factors. First, he presented as a trauma patient rather than as a patient with withdrawal symptoms, as has been seen in most case reports. Second, he had surgery and was given morphine during his hospital stay, both of which are known to cause delirium. However, it is most likely that he was experiencing GHB withdrawal, because many of his symptoms preceded both the surgery and his brief morphine use. We present this case to illustrate both the importance of considering GHB withdrawal in the differential of the causes of delirium and the need to treat the cause (in this case, GHB withdrawal was treated with diazepam), rather than attempting to manage the symptoms with a neuroleptic. 
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